Pancreatitis in Acute Promyelocytic Leukemia: Drug‑induced or Differentiation Syndrome?

Dibyendu De; Uttam Kumar Nath; Prantar Chakrabarti

doi:10.4103/ijmpo.ijmpo_36_16

Indian Journal of Medical and Paediatric Oncology, Table of Contents

CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2017; 38(03): 371-373
DOI: 10.4103/ijmpo.ijmpo_36_16

Case Report

Pancreatitis in Acute Promyelocytic Leukemia: Drug‑induced or Differentiation Syndrome?

Dibyendu De

Department of Hematology and Hemato-Oncology, The Mission Hospital, Durgapur, West Bengal, India

,

Uttam Kumar Nath

Department of Hematology, Institute of Hematology and Transfusion Medicine, Medical College, Kolkata, West Bengal, India

,

Prantar Chakrabarti

Department of Hematology, NRS Medical College, Kolkata, West Bengal, India

› Author Affiliations

Abstract

PDF Download

Abstract

Acute promyelocytic leukemia (APL) constitutes about 15% of all acute myeloid leukemia patients and can now be treated even without any chemotherapy, with all-trans-retinoic acid (ATRA) and arsenic trioxide (ATO). Acute pancreatitis (AP) is a rare adverse event in APL, which is primarily reported to be secondary to hypertriglyceridemia. Here, we have reported AP developed in a patient of APL, during induction with ATRA and ATO, but it was not associated with hypertriglyceridemia. Rather, it was associated with respiratory distress and weight gain, coincidental leukocytosis, bilateral pleural effusion, and edematous pancreatitis without any necrosis. Hence, AP in this case is diagnosed to be a manifestation of differentiation syndrome, and it responded to steroid.

Keywords

Acute promyelocytic leukemia - all-trans-retinoic acid - arsenic - differentiation syndrome - pancreatitis

PDF (794 kb)

References

References
1 Warrell RP Jr., de The H, Wang ZY, Degos L. Acute promyelocytic leukemia. N Engl J Med 1993;329:17-89.
2 Soignet SL, Maslak P, Wang ZG, Jhanwar S, Calleja E, Dardashti LJ, et al. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med 1998;339:1341-8.
3 Hatake K, Uwai M, Ohtsuki T, Tomizuka H, Izumi T, Yoshida M, et al. Rare but important adverse effects of all-trans retinoic acid in acute promyelocytic leukemia and their management. Int J Hematol 1997;66:13-9.
4 Koshy GK, Kumar S, Hertan HI. All-trans-retinoic acid (tretinoin) induced fatal acute pancreatitis. Am J Gastroenterol 2003;98 (Suppl S9):S164.
5 Abou Chacra L, Ghosn M, Ghayad E, Honein K. A case of pancreatitis associated with all-trans-retinoic acid therapy in acute promyelocytic leukemia. Hematol J 2001;2:406-7.
6 Izumi T, Hatake K, Miura Y. Acute promyelocytic leukemia. N Engl J Med 1994;330:141.
7 Teng HW, Bai LY, Chao TC, Wang WS, Chen PM. Acute pancreatitis during all-trans-retinoic acid treatment for acute promyelocytic leukemia in a patient without overt hypertriglyceridemia. Jpn J Clin Oncol 2005;35:94-6.
8 Zaloga GP, Deal J, Spurling T, Richter J, Chernow B. Unusual manifestations of arsenic intoxication. Am J Med Sci 1985;289:210-4.
9 Yamano T, Yokote T, Akioka T, Hara S, Oka T, Tsuji M, et al. Acute pancreatitis during the treatment of relapsed acute promyelocytic leukemia with As2O3. Rinsho Ketsueki 2006;47:23-5.
10 Hantson P, Haufroid V, Buchet JP, Mahieu P. Acute arsenic poisoning treated by intravenous dimercaptosuccinic acid (DMSA) and combined extrarenal epuration techniques. J Toxicol Clin Toxicol 2003;41:1-6.
11 Connelly S, Zancosky K, Farah K. Arsenic-induced pancreatitis. Case Rep Gastrointest Med 2011;2011:758947.
12 Ratnaike RN. Acute and chronic arsenic toxicity. Postgrad Med J 2003;79:391-6.